IFNAR1在口腔鳞状细胞癌中的表达及意义

doi:10.19438/j.cjoms.2017.03.010

中国口腔颌面外科杂志 ›› 2017, Vol. 15 ›› Issue (3): 240-244.doi: 10.19438/j.cjoms.2017.03.010

IFNAR1在口腔鳞状细胞癌中的表达及意义

朱黎琳¹,²，杨文艺¹，马海龙¹*，胡镜宙¹*

1.上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科，上海市口腔医学重点实验室, 上海 200011；
2.复旦大学附属中山医院青浦分院口腔科，上海 201700

收稿日期:2016-10-17 修回日期:2017-01-26 出版日期:2017-05-20 发布日期:2017-06-09
通讯作者: 国家自然科学基金（31140007，81472516）；上海市自然科学基金（14ZR1424200）
作者简介:朱黎琳（1985-），女，在读硕士研究生，主治医师，E-mail:zll19850507@163.com
基金资助:
胡镜宙，E-mail: huyayi@163.com；马海龙，E-mail:mahl21@sjtu.edu.cn。*共同

Expression and significance of IFNAR1 in oral squamous cell carcinoma

ZHU Li-lin¹,², YANG Wen-yi¹, MA Hai-long¹, HU Jing-zhou¹.

1.Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology. Shanghai 200011；
2.Department of Stomatology, Zhongshan Hospital Qingpu Branch, Fudan University. Shanghai 201700, China

Received:2016-10-17 Revised:2017-01-26 Online:2017-05-20 Published:2017-06-09

摘要/Abstract

摘要： 目的：观察Ⅰ型干扰素受体1（type I interferon receptor 1，IFNAR1）在口腔鳞状细胞癌（oral squamous cell carcinoma，OSCC）及正常口腔黏膜中的表达，探讨其与患者临床特征及预后的关系。方法：应用免疫组织化学方法检测IFNAR1在108例OSCC及16例正常黏膜组织中的表达水平，分析IFNAR1的表达水平与OSCC临床病理特征的关系。采用SPSS17.0软件包对数据进行统计学分析。结果：IFNAR1在OSCC的表达水平比正常黏膜组织高。IFNAR1的表达水平与T分期、颈淋巴结转移、TNM分期及病理分化程度显著相关（P<0.05）；与患者的性别、年龄、发生部位、吸烟和饮酒无相关性（P>0.05）。IFNAR1表达对OSCC患者生存预后的HR=1.879 （95%CI=0.967-3.651，P=0.063）。Log-rank检验显示，IFNAR1表达高低与OSCC患者预后相关（P=0.057）。结论：IFNAR1在OSCC患者中高表达，其表达上调对OSCC是一个潜在的危险因子，与OSCC患者的预后有相关趋势。

关键词: IFNAR1, 免疫组织化学, 口腔鳞状细胞癌

Abstract: PURPOSE: To investigate the expression of type I interferon receptor 1(IFNAR1) in oral squamous cell carcinoma (OSCC) and normal mucosa, and to explore its relationship with clinical pathological characteristics and prognosis. METHODS: The expression of IFNAR1 in 108 cases with OSCC and 16 cases with normal oral mucosa was detected by immunohistochemistry. The relationship between the expression of IFNAR1 in OSCC tissues and clinical pathological characteristics were analyzed. The data were analyzed with SPSS17.0 software package. RESULTS: The expression of IFNAR1 in OSCC was significantly higher than that in normal oral mucosa. The expression of IFNAR1 was closely correlated with T stage, cervical lymph node metastasis, TNM stage and pathological differentiation (P<0.05); while gender, age, location, smoking and drinking had no correlation with IFNAR1 (P>0.05). IFNAR1 expression was an important factor to predict prognosis of OSCC patients with HR=1.879(95% CI=0.967-3.651, P=0.063). Patients with higher expression of IFNAR1 had poorer prognosis shown by Log-rank test (P=0.057). CONCLUSIONS: The expression of IFNAR1 in OSCC was significantly higher than that in normal oral mucosa, and it is a potential risk factor for OSCC. It has a tendency to be related to the prognosis of OSCC patients. IFNAR1 expression in tumor tissues can be a surrogate to select patients who can benefit from interferon alpha treatment in OSCC.

Key words: IFNAR1, Immunohistochemistry, Oral squamous cell carcinoma

中图分类号:

R739.8

朱黎琳,杨文艺，马海龙*，胡镜宙*. IFNAR1在口腔鳞状细胞癌中的表达及意义[J]. 中国口腔颌面外科杂志, 2017, 15(3): 240-244.

ZHU Li-lin, YANG Wen-yi, MA Hai-long, HU Jing-zhou.. Expression and significance of IFNAR1 in oral squamous cell carcinoma[J]. China J Oral Maxillofac Surg, 2017, 15(3): 240-244.

参考文献

[1] Rivera C. Essentials of oral cancer [J]. Int J Clin Exp Pathol, 2015, 8(9): 11884-11894.
[2] Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer [J]. Oral Oncol, 2009, 45(4-5): 309-316.
[3] Zhang SK, Zheng R, Chen Q, et al. Oral cancer incidence and mortality in China, 2011 [J]. Chin J Cancer Res, 2015, 27(1):44-51.
[4] Chill JH, Quadt SR, Levy R, et al. The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding [J]. Structure, 2003, 11(7): 791-802.
[5] Takaoka A, Yanai H. Interferon signalling network in innate defence [J]. Cell Microbiol, 2006, 8(6): 907-922.
[6] de Weerd NA, Samarajiwa SA, Hertzog PJ. Type I interferon receptors: biochemistry and biological functions [J]. J Biol Chem, 2007, 282(28): 20053-20057.
[7] Wang BX, Rahbar R, Fish EN. Interferon: current status and future prospects in cancer therapy [J]. J Interferon Cytokine Res, 2011, 31(7): 545-552.
[8] Wagner TC, Velichko S, Chesney SK, et al. Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors [J]. Int J Cancer, 2004, 111(1): 32-42.
[9] Booy S, Hofland LJ, Waaijers AM, et al. Type I interferon receptor expression in human pancreatic and periampullary cancer tissue [J]. Pancreas, 2015, 44(1): 99-105.
[10] Kamai T, Yanai Y, Arai K, et al. Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis [J]. BMC Cancer, 2007, 7: 159.
[11] Chang LC, Fan CW, Tseng WK, et al. IFNAR1 is a predictor for overall survival in colorectal cancer and its mRNA expression correlated with IRF7 but not TLR9 [J]. Medicine(Baltimore), 2014, 93(29): e349.
[12] Parker BS, Rautela J, Hertzog PJ. Antitumour actions of interferons: implications for cancer therapy [J]. Nat Rev Cance, 2016, 16(3): 131-144.
[13] Wu CF, Andzinski L, Kasnitz N, et al. The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung [J]. Int J Cancer, 2015, 137(4): 837-847.
[14] Bhattacharya S, HuangFu WC, Dong G, et al. Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses [J]. Oncogene, 2013, 32(36): 4214-4221.

[1]	热孜万姑丽·亚森, 买热拍提·买明, 李晨曦, 龚忠诚. 牙龈卟啉单胞菌促进口腔鳞状细胞癌进展的作用及机制研究进展[J]. 中国口腔颌面外科杂志, 2023, 21(2): 186-190.
[2]	兰嵘, 阮敏, 韩楠男, 王凤. 左下种植修复后发生植体周围鳞状细胞癌1例报告[J]. 中国口腔颌面外科杂志, 2023, 21(2): 203-205.
[3]	苏姿尚, 崔文丽, 张梦云, 姚志涛. 口腔鳞状细胞癌患者颈部淋巴结特征与预后的关系[J]. 中国口腔颌面外科杂志, 2023, 21(1): 41-48.
[4]	钱敏, 沈月洪, 吴利, 杨宏宇. 舌根转移性小细胞神经内分泌癌1例报告及文献复习[J]. 中国口腔颌面外科杂志, 2022, 20(2): 202-205.
[5]	杨彩秀, 卜令学, 陈立强, 范存晖, 王双义. 颌面部原发性皮肤间变大细胞淋巴瘤1例报告及文献复习[J]. 中国口腔颌面外科杂志, 2021, 19(4): 380-384.
[6]	孔钰, 杨小琛, 陶月琴, 周凯, 林浩志, 侯峰, 冯元勇, 陈云庆, 蒋艳霞, 宋凯, 尚伟. 68例HPV相关口咽鳞癌患者生存分析[J]. 中国口腔颌面外科杂志, 2021, 19(3): 238-243.
[7]	陈秀敏, 刘族志, 林建能. 血浆miR-136-5p表达水平对口腔鳞状细胞癌患者预后预测的价值[J]. 中国口腔颌面外科杂志, 2020, 18(6): 526-530.
[8]	梁思源, 赵铜超, 周知航, 琚梧桐, 刘莹, 张志愿, 钟来平. 可利霉素对口腔鳞癌细胞生物学活性的影响[J]. 中国口腔颌面外科杂志, 2020, 18(4): 308-313.
[9]	原振英, 李明, 管翠强, 闫星泉, 南欣荣. 腮腺T细胞淋巴瘤1例报告及文献复习[J]. 中国口腔颌面外科杂志, 2020, 18(2): 186-189.
[10]	王锋, 李翔, 王宇帆, 杨宏宇. 环状RNA在口腔鳞状细胞癌中的作用探讨[J]. 中国口腔颌面外科杂志, 2019, 17(6): 496-502.
[11]	李翔, 苏文, 张寒雨, 张璧茹, 杨宏宇. 沉默环状RNA hsa_circ_0006677 表达对口腔鳞状细胞癌迁移及侵袭能力的影响[J]. 中国口腔颌面外科杂志, 2019, 17(4): 289-294.
[12]	朱东旺, 孙文文, 赵铜超, 钟来平, 张陈平, 张志愿. 人口腔鳞状细胞癌细胞系TSCC2016的建立及生物学特性分析[J]. 中国口腔颌面外科杂志, 2019, 17(3): 204-209.
[13]	顾挺，胡宇华，夏荣辉，田臻，王丽珍，张春叶，李江. 免疫组织化学双染技术在唾液腺淋巴上皮性病变中的应用评价[J]. 中国口腔颌面外科杂志, 2019, 17(3): 216-220.
[14]	付永, 马捷, 刘莹, 谈亦然, 琚梧桐, 孙文文, 赵铜超, 王旻, 王丽珍, 李江, 张陈平, 张志愿, 钟来平. TP53截断突变作为局部晚期口腔鳞癌诱导化疗预测性生物标志物的探讨[J]. 中国口腔颌面外科杂志, 2018, 16(4): 322-327.
[15]	鞠侯雨，张黎明，任国欣. mTOR调控口腔鳞状细胞癌增殖转移的机制研究[J]. 中国口腔颌面外科杂志, 2017, 15(5): 397-401.

IFNAR1在口腔鳞状细胞癌中的表达及意义

Expression and significance of IFNAR1 in oral squamous cell carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价